Verinnogen raises £500k to advance cancer drug development

12 May

Written By Alexandra Collingbourne

Alexandra Collingbourne

Signaloid announces preview of new ASIC targeted at physical AI and robotics applications

Rethinking Clinical Trials with Synthetic Control Arms